Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains ...
FDA Drug Recall #D-1384-2012 — Class III — April 23, 2012
Recall Summary
| Recall Number | D-1384-2012 |
| Classification | Class III — Low risk |
| Date Initiated | April 23, 2012 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Teva Pharmaceuticals USA, Inc. |
| Location | Sellersville, PA |
| Product Type | Drugs |
| Quantity | 40,750 Dispensers |
Product Description
Jolessa (levonorgestrel/ethinyl estradiol tablets, USP) 0.15 mg/0.03 mg, each Dispenser contains 91 tablets, 91 Day Regimen, Rx Only, Shaping Women's Health, Manufactured by: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-9123-66.
Reason for Recall
Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.
Distribution Pattern
Nationwide
Lot / Code Information
Lot #'s 33801826A, Exp 1/2013; 33802144A; 33802323A, Exp 3/2013; 33802519A, Exp 6/2013
Other Recalls from Teva Pharmaceuticals USA, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0518-2020 | Class II | Valganciclovir Hydrochloride for Oral Solution,... | Nov 4, 2019 |
| D-747-2014 | Class III | Fluconazole Oral Suspension, 10 mg/mL, 35 ml bo... | Nov 14, 2013 |
| D-1061-2014 | Class II | Valacyclovir Hydrochloride Tablets, 1 g, 30 cou... | Nov 8, 2013 |
| D-928-2013 | Class II | CARBOplatin Injection, 600 mg/60ml, MultiDose, ... | Aug 13, 2013 |
| D-924-2013 | Class II | Propranolol Hydrochloride Tablets, USP, 10 mg, ... | Aug 6, 2013 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.